Cargando…

Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD

One of the primary objectives in management of chronic obstructive pulmonary disease (COPD) is preventing decrease in lung function and reducing the annual number of acute exacerbations of COPD (AECOPD). An oral course of systemic corticosteroids is a commonly used treatment in AECOPD. We hypothesiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, SL, Backer, V, Godtfredsen, Nina Skavlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958466/ https://www.ncbi.nlm.nih.gov/pubmed/28718320 http://dx.doi.org/10.1177/1479972317721929

Ejemplares similares

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care
por: Savran, Osman, et al.
Publicado: (2020)

Meta-analysis of routine blood tests as predictors of mortality in COPD
por: Lomholt, Frederikke K., et al.
Publicado: (2014)

Inspiratory muscle strength and walking capacity in patients with COPD
por: Kofod, Linette Marie, et al.
Publicado: (2019)

Interorganisational Integration: Healthcare Professionals’ Perspectives on Barriers and Facilitators within the Danish Healthcare System
por: Lyngsø, Anne Marie, et al.
Publicado: (2016)

COPD exacerbations in general practice: variability in oral prednisolone courses
por: de Vries, Marianne, et al.
Publicado: (2012)

Instruments to assess integrated care: a systematic review
por: Lyngsø, Anne Marie, et al.
Publicado: (2014)

A qualitative study of integrated care from the perspectives of patients with chronic obstructive pulmonary disease and their relatives
por: Wodskou, Pernille Maria, et al.
Publicado: (2014)

Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial
por: Hansen, Henrik, et al.
Publicado: (2020)

Inter-Day Test–Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD
por: Hansen, Henrik, et al.
Publicado: (2021)

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
por: Mosbech, Christiane Hammershaimb, et al.
Publicado: (2023)

Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis
por: Hansen, Henrik, et al.
Publicado: (2023)

Optimizing COPD treatment in patients with lung- or head and neck cancer does not improve quality of life – a randomized, pilot, clinical trial
por: Gottlieb, Magnus, et al.
Publicado: (2020)

Prednisolone for COPD exacerbations: time for a rethink
por: Ramakrishnan, Sanjay
Publicado: (2023)

Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
por: Tacey, Alexander, et al.
Publicado: (2019)

Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis
por: Ryrsø, Camilla Koch, et al.
Publicado: (2018)

Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
por: Miravitlles, Marc, et al.
Publicado: (2014)

Observational study on the palatability and tolerability of oral prednisolone and oral dexamethasone in children in Saudi Arabia and the UK
por: Aljebab, Fahad, et al.
Publicado: (2018)

Are the “critical” inspiratory constraints actually decisive to limit exercise tolerance in COPD?
por: Marillier, Mathieu, et al.
Publicado: (2020)

COPD, stage and treatment in a large outpatient clinic
por: Holm, Claire Præst, et al.
Publicado: (2017)

COPD online-rehabilitation versus conventional COPD rehabilitation – rationale and design for a multicenter randomized controlled trial study protocol (CORe trial)
por: Hansen, Henrik, et al.
Publicado: (2017)

Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
por: Dyreborg, Anders, et al.
Publicado: (2016)

Prednisolone induced pneumatosis coli and pneumoperitoneum
por: Goh, Serene S N, et al.
Publicado: (2022)

Pharmacokinetics of Orally Administered Prednisolone in Alpacas
por: Videla, Ricardo, et al.
Publicado: (2021)

Impact of bronchodilator therapy on exercise tolerance in COPD
por: Aguilaniu, B
Publicado: (2010)

Apparent steroid resistance associated with prednisolone suspension
por: Sathe, K. P.
Publicado: (2014)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Does roflumilast induce phagocytic activity in COPD patients?
por: Ghosh, Baishakhi, et al.
Publicado: (2015)

Does prior exercise affect oral glucose tolerance test results?
por: Titchenal, C Alan, et al.
Publicado: (2008)

Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2013)

COPD and exercise: does it make a difference?
por: Spruit, Martijn A., et al.
Publicado: (2016)

Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD
por: Hansen, Henrik, et al.
Publicado: (2018)

COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
por: Savran, Osman, et al.
Publicado: (2019)

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance
por: Ambrosino, Nicolino, et al.
Publicado: (2008)

Nutritional State and COPD: Effects on Dyspnoea and Exercise Tolerance
por: Tramontano, Angela, et al.
Publicado: (2023)

Single dose intravenous methyl prednisolone versus oral prednisolone in Bell's palsy: A randomized controlled trial
por: Giri, Prithvi, et al.
Publicado: (2015)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
por: Kamstrup, Peter, et al.
Publicado: (2023)

Cases of aquaporin-4-positive neuromyelitis optica spectrum disorder with successful tapering of prednisolone to less than 3 mg/day after satralizumab administration
por: Nakamagoe, Kiyotaka, et al.
Publicado: (2023)

Methyl prednisolone vs Dexamethasone in Management of COPD Exacerbation; a Randomized Clinical Trial
por: Emami Ardestani, Mohammad, et al.
Publicado: (2017)

Feasibility of a telecare solution for patients admitted with COPD exacerbation: screening data from a pulmonary ward in a university hospital
por: Gottlieb, Magnus, et al.
Publicado: (2014)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
por: Savran, Osman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g539p82b2ljtt9a0v2tq2gohud